Dyslipidemia Essentials integrates the latest clinical guidelines and trials into a practical step-by-step guide to the management of dyslipidemia. Important clinical trials, common management pitfalls, and other cardiovascular risk reduction measures are also emphasized.

Dyslipidemia has intricate physiopathology, often due to genetic, diet and lifestyle factors. It has various adverse impacts, especially in the development of chronic non-communicable diseases. Important ethnic differences exist due to the prevalence and types of lipid ailment, while elevated serum total and LDL-cholesterol are the main concerns in the developed countries, in other countries hypertriglyceridemia and low HDL-cholesterol are more widespread. The growing cases of obesity, changes in lifestyle and environmental factors will make dyslipidemia a global medical and public health peril, not only for adults but also for children. Various experimental and clinical researches are going on related to the basic mechanisms and treatment of dyslipidemia. This book will deliver an overview of dyslipidemia from distinct facets of physiopathology, ethnic differences, genetics and role in metabolic syndrome.

An essential resource for all cardiologists, internists, and medical residents, Pharmacological Management of Hypertension and Dyslipidemia assists clinicians in the treatment of hypertension and high cholesterol, the two most easily diagnosed and treatable risk factors for cardiovascular disease. This concise yet complete handbook includes the scientific background for each drug class presented, and includes a review of the science supporting the utilization of the agents in particular patient situations. The medications and their doses and dosage forms are presented in easy to use tables, so that the practitioners can quickly access the information to make their treatment decisions, whether they are in the hospital or in an outpatient setting.